Report questions hasty vax plant shutdowns in India; painkiller abuse deterrent comes under FDA scrutiny;

> India's Union health minister is being accused of ordering the shutdown of three public sector vaccine manufacturing units without a clear analysis. Article

> The FDA questions the deterrent in a painkiller reformulated to curb abuse. Article

> Almac in Ireland has completed a three-story expansion of its pharma services division lab and office areas, adding 30,000 square feet. Article

> Millipore has launched the Milliflex Quantum rapid microbial detection system, which combines membrane filtration and fluorescent staining. Item

> Bioniche Life Sciences has scored $750,000 in funding from the Federal Economic Development Agency for Southern Ontario for development of a pilot-scale fermentation facility. Release

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.